Systematic review and meta-analysis of risk prediction models for retinopathy of prematurity in preterm infants
View abstract on PubMed
Summary
This summary is machine-generated.Risk prediction models for retinopathy of prematurity (ROP) show good potential for clinical screening in preterm infants. However, moderate bias and limited validation hinder their widespread use.
Area Of Science
- Neonatal Ophthalmology
- Medical Informatics
- Public Health
Background
- Retinopathy of prematurity (ROP) is a leading cause of blindness in preterm infants due to abnormal retinal vascular development.
- Existing ROP risk prediction models vary significantly in methodology and performance, limiting their clinical applicability.
- Reliable ROP risk prediction is essential for optimizing screening and intervention strategies in neonatal care.
Purpose Of The Study
- To systematically review and meta-analyze the effectiveness of current risk prediction models for ROP in preterm infants.
- To evaluate the discriminative ability and identify limitations of existing ROP prediction models.
- To provide evidence-based recommendations for developing more robust and generalizable ROP screening tools.
Main Methods
- Systematic literature search of PubMed, Cochrane Library, Web of Science, and Embase databases.
- Included 28 studies (2009-2025) with 72,991 preterm infants, assessing risk of bias using PROBAST.
- Performed meta-analysis, heterogeneity testing, subgroup, and sensitivity analyses to evaluate model performance (pooled AUC=0.87).
Main Results
- All ROP risk prediction models exhibited a moderate risk of bias, often due to retrospective designs and inadequate confounding factor control.
- The pooled discriminative ability (AUC) was 0.87, but significant heterogeneity (I²=99.2%) was observed across models and regions.
- Subgroup analyses revealed high heterogeneity in traditional statistical and machine learning models, and regional variations in Asia and North America + Europe.
Conclusions
- Current ROP risk prediction models demonstrate good clinical potential and discriminative ability for screening preterm infants.
- Moderate risk of bias and insufficient validation (especially external) limit the generalizability of existing models.
- Future research should focus on prospective designs, larger sample sizes, and rigorous external validation to enhance ROP model accuracy and universality.

